BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 16141466)

  • 1. Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease.
    Mei C; Mao Z; Shen X; Wang W; Dai B; Tang B; Wu Y; Cao Y; Zhang S; Zhao H; Sun T
    Nephrol Dial Transplant; 2005 Nov; 20(11):2368-75. PubMed ID: 16141466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of SPARC and its impact on proliferation and apoptosis in ADPKD cyst-lining epithelia.
    Wang W; Mei C; Tang B; Zhao H; Xu C; Li Z; Shen X; Fu W; Dai B
    Nephrol Dial Transplant; 2006 May; 21(5):1278-88. PubMed ID: 16421164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Na+/H+ exchanger regulatory factor 1 in autosomal-dominant polycystic kidney disease.
    Wang JQ; Qin F; Zhu L
    J Int Med Res; 2015 Oct; 43(5):629-38. PubMed ID: 26142394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone inhibits cell proliferation by inducing G1 cell cycle arrest and apoptosis in ADPKD cyst-lining epithelia cells.
    Liu Y; Dai B; Fu L; Jia J; Mei C
    Basic Clin Pharmacol Toxicol; 2010 Jun; 106(6):523-30. PubMed ID: 20210794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keratinocyte growth factor-1 expression in healthy and diseased human periodontal tissues.
    Li M; Firth JD; Putnins EE
    J Periodontal Res; 2005 Apr; 40(2):118-28. PubMed ID: 15733146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of keratinocyte growth factor and keratinocyte growth factor receptor and its impact on Hela cells].
    Lu L; Hu LN; Li SQ; Jia HJ; Li JK; Wang DF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):437-9. PubMed ID: 17593825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocyte Growth Factor Regulation of Aryl Hydrocarbon Receptor Activation in Colorectal Cancer Cells.
    Yin J; Sheng B; Pu A; Han B; Yang K; Wang Q; Sun L; Yang H
    Dig Dis Sci; 2016 Feb; 61(2):444-52. PubMed ID: 26514676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
    Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
    Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratinocyte growth factor and its receptor expression in chronic otitis media with and without cholesteatoma.
    Harabagiu OE; Cosgarea M; Mogoantă CA; Leucuţa DC; Maniu AA
    Rom J Morphol Embryol; 2017; 58(4):1333-1338. PubMed ID: 29556625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of keratinocyte growth factor and its receptor in human endometrial cancer in cooperation with steroid hormones.
    Ishikawa A; Kudo M; Nakazawa N; Onda M; Ishiwata T; Takeshita T; Naito Z
    Int J Oncol; 2008 Mar; 32(3):565-74. PubMed ID: 18292933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor.
    Wallace DP; Quante MT; Reif GA; Nivens E; Ahmed F; Hempson SJ; Blanco G; Yamaguchi T
    Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1463-71. PubMed ID: 18753297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid.
    Nichols MT; Gidey E; Matzakos T; Dahl R; Stiegmann G; Shah RJ; Grantham JJ; Fitz JG; Doctor RB
    Hepatology; 2004 Oct; 40(4):836-46. PubMed ID: 15382115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21 is decreased in polycystic kidney disease and leads to increased epithelial cell cycle progression: roscovitine augments p21 levels.
    Park JY; Schutzer WE; Lindsley JN; Bagby SP; Oyama TT; Anderson S; Weiss RH
    BMC Nephrol; 2007 Aug; 8():12. PubMed ID: 17714589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratinocyte growth factor and its receptor in the rhesus macaque placenta during the course of gestation.
    Izumi S; Slayden OD; Rubin JS; Brenner RM
    Placenta; 1996; 17(2-3):123-35. PubMed ID: 8730882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer.
    Cho K; Matsuda Y; Ueda J; Uchida E; Naito Z; Ishiwata T
    Int J Oncol; 2012 Apr; 40(4):1040-8. PubMed ID: 22159401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulated expression of keratinocyte growth factor and its receptor in experimental and human liver fibrosis.
    Otte JM; Schwenger M; Brunke G; Schmitz F; Otte C; Kiehne K; Kloehn S; Mönig H; Schmidt WE; Herzig KH
    Regul Pept; 2007 Dec; 144(1-3):82-90. PubMed ID: 17692400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone inhibits insulin-like growth factor‑1-induced polycystic kidney disease cell growth and p70S6 kinase activation.
    Liu C; Zhang Y; Yuan L; Fu L; Mei C
    Mol Med Rep; 2013 Sep; 8(3):861-4. PubMed ID: 23864113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-β inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells.
    Elberg D; Jayaraman S; Turman MA; Elberg G
    Exp Cell Res; 2012 Aug; 318(13):1508-16. PubMed ID: 22504005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal overexpression of collagen IV characterizes the initiation of epithelial changes in polycystic kidney disease.
    Schäfer K; Bader M; Gretz N; Oberbäumer I; Bachmann S
    Exp Nephrol; 1994; 2(3):190-5. PubMed ID: 7922272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental and hormonal regulation of keratinocyte growth factor expression and action in the ovarian follicle.
    Parrott JA; Skinner MK
    Endocrinology; 1998 Jan; 139(1):228-35. PubMed ID: 9421419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.